CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation
Eon Ju Jeon, Eui Dal Jung
Endocrinol Metab. 2014;29(1):33-39.   Published online March 14, 2014
DOI: https://doi.org/10.3803/EnM.2014.29.1.33

Excel Download

Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation
Endocrinology and Metabolism. 2014;29(1):33   Crossref logo
Link1 Link2 Link3

Letter: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.)
Endocrinology and Metabolism. 2014;29(2):206   Crossref logo
Link1 Link2 Link3

Response: Diagnostic Whole-Body Scan May Not Be Necessary for Intermediate-Risk Patients with Differentiated Thyroid Cancer after Low-Dose (30 mCi) Radioactive Iodide Ablation (Endocrinol Metab 2014;29:33-9, Eon Ju Jeon et al.)
Endocrinology and Metabolism. 2014;29(2):208   Crossref logo
Link1 Link2 Link3

Preablation Diagnostic Whole-Body Scan vs Empiric Radioactive Iodine Ablation in Differentiated Thyroid Cancer: Cost-effectiveness Analysis
Otolaryngology–Head and Neck Surgery. 2020;019459982096698   Crossref logo
Link1 Link2 Link3

Cost-Effectiveness of Pre-Ablation Diagnostic Whole-Body Scan vs Empiric Radioactive Iodine Ablation in Differentiated Thyroid Cancer
Journal of the American College of Surgeons. 2020;231(4):S74-S75   Crossref logo
Link1 Link2

Longer-term recurrence rate after low versus high dose radioiodine ablation for differentiated thyroid Cancer in low and intermediate risk patients: a meta-analysis
BMC Cancer. 2020;20(1):   Crossref logo
Link1 Link2 Link3

Recurrence Rates in Patients with Intermediate-Risk Differentiated Thyroid Cancer Are Similar after Low-Dose and High-Dose Radioiodine Ablation in a Korean Series
Clinical Thyroidology. 2017;29(2):55-57   Crossref logo
Link1 Link2

Less than 2% of the Low- and Intermediate-Risk Differentiated Thyroid Cancers Show Distant Metastases at Post-Ablation Whole-Body Scan
European Thyroid Journal. 2018;8(2):90-95   Crossref logo
Link1 Link2

Are There Disadvantages in Administering 131I Ablation Therapy in Patients With Differentiated Thyroid Carcinoma Without a Preablative Diagnostic 131I Whole-Body Scan?
Yearbook of Endocrinology. 2006;2006:306-309   Crossref logo
Link1 Link2

Value of Diagnostic Radioiodine Whole-Body Scanning After Initial Therapy in Patients with Differentiated Thyroid Cancer at Intermediate and High Risk for Recurrence
Thyroid. 2012;22(11):1165-1169   Crossref logo
Link1 Link2